Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Current Assets (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Current Assets for 6 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 83.86% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 83.86% year-over-year, with the annual reading at $1.6 million for FY2025, 83.86% up from the prior year.
  • Current Assets for Q4 2025 was $1.6 million at BioScience Health Innovations, down from $2.0 million in the prior quarter.
  • The five-year high for Current Assets was $2.0 million in Q3 2025, with the low at $6314.0 in Q3 2021.
  • Average Current Assets over 5 years is $525175.8, with a median of $95001.0 recorded in 2023.
  • The sharpest move saw Current Assets tumbled 69.39% in 2021, then soared 829.48% in 2025.
  • Over 5 years, Current Assets stood at $6314.0 in 2021, then skyrocketed by 348.89% to $28343.0 in 2022, then skyrocketed by 229.49% to $93388.0 in 2023, then surged by 807.77% to $847751.0 in 2024, then skyrocketed by 83.86% to $1.6 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $1.6 million, $2.0 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.